BioFuture 2030 is the first industry-led economic strategy to grow Nova Scotia’s health and life sciences sector.
The plan leverages our science, talent, and infrastructure to transform our economy by growing globally-competitive companies, attracting millions of investment dollars, and creating high-value jobs for Atlantic Canadians.
The health and life sciences sector is one of our greatest economic opportunities. The companies in our sector are tackling the biggest challenges facing our region by improving the sustainability of our healthcare system, developing tools to assist our aging population, providing healthier foods for a growing global population, and creating sustainable bioproducts.
BioFuture 2030 is a collaborative plan and call-to-action for the players in Atlantic Canada’s health and life sciences sector – whether you are in the research community, the business community, or different levels of government.
BioFuture 2030 News
News Release: Health and Life Sciences Companies in Nova Scotia Develop Vaccines, Provide Medical Supplies to Fight COVID-19
Halifax, NS – March 26th, 2020 – As the impact of the novel coronavirus (COVID-19) pandemic continues to grow globally, Nova Scotia's innovative health and life sciences community including IMV Inc., Sona Nanotech, BioVectra and others are ramping up efforts to study...
News Release: Atlantic Canadian Medtech Companies Invited to Pitch for $100K at Five-Part Health Challenge Events
For Immediate Release: Atlantic Canadian Medtech Companies Invited to Pitch for $100K at Five-Part Health Challenge Events HALIFAX, NS (February 28, 2020) – To further drive innovation in the health ecosystem, the Nova Scotia Health Authority, BioNova, the Atlantic...
BioTalent Canada and BioNova launch new provincial life sciences job board
HALIFAX, NS – February 10, 2020 – Today, BioTalent Canada and BioNova announced the launch of The PetriDish™ BioNova job board – giving companies in one of Canada’s fastest growing bio-economy hubs a platform to attract highly-skilled talent. According to BioTalent...
ENTREVESTOR – Biotech Segment Continues To Grow
Read original Entrevestor article here One of the strongest developments in the Atlantic Canadian startup community in recent years is the development of the life sciences segment – both the biotech companies and the ecosystem that supports them. Five years ago, these...
Entrevestor – BioNova Calls for Tax Credit Reforms
See original Entrevestor article here While applauding recent investment tax credit reforms in Nova Scotia, the province’s life sciences association wants further improvements, including offering the credits to investors outside the region. BioNova, the group that...
Province Announces Innovation Equity Tax Credit
Read original announcement here Nova Scotia startup companies and small and medium-sized businesses will benefit from more investment, thanks to a new Innovation Equity Tax Credit launched today by Finance and Treasury Board Minister Karen Casey. The new tax credit...
ENTREVESTOR: Momentum for Tax Credit Revamp
The investment tax credit discussion in Atlantic Canada has been intensifying lately, and now Senator Colin Deacon is taking up the cause. These provincial taxation measures give private investors a tax break if they invest in approved companies. All four Atlantic...
ENTREVESTOR: A Plan To Double NS Biotech by 2030
Read the original article here. BioNova, the association for Nova Scotia’s life sciences industry, has released its plan to at least double the biotech sector in the next 12 years, creating 2,700 jobs with average salaries of more than $100,000. Titled BioFuture 2030,...
BioNova Unveils Plan to Grow Nova Scotia’s Health and Life Sciences Sector
NEWS RELEASE: October 10, 2018 – Halifax, NOVA SCOTIA – Today BioNova released BioFuture 2030, the first industry-led economic strategy to grow Nova Scotia’s health and life sciences sector. BioFuture 2030 leverages the expertise and resources within the sector to...
Report from Canada’s Economic Strategy Tables: Health and Biosciences
Read full plan here Vision By 2025, Canada will double the size of the health and biosciences sector and become a top-three global hub by: leveraging and advancing innovative technologies; attracting and retaining capital, skills and talent; and ensuring a vibrant ecosystem that will unleash the full potential of the sector and lead to improved […]
#BioFuture2030 #LeadingLifeScience